Dry eye in patients with fibromyalgia and its relevance to functional and emotional status

Cornea

Volumn 32, Issue 6, 2013, Pages 862-866

  Türkyilmaz, Kemal ^a   Türkyilmaz, Ayşegül Küçükali ^a   Kurt, Emine Eda ^b   Kurt, Ali ^c   Öner, Veysi ^a  

^a RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

^b Acibadem Hospital   (Turkey)

^c Maya Eye Hospital   (Turkey)

Author keywords

Dry eye; Fibromyalgia; Functional and emotional status; Tear osmolarity

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRY EYE; EMOTION; FEMALE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; FUNCTIONAL STATUS; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OCULAR SURFACE DISEASE; OSMOLARITY; PRIORITY JOURNAL; SCHIRMER TEST; VISUAL ANALOG SCALE;

ADULT; AFFECTIVE SYMPTOMS; DEPRESSIVE DISORDER; DRY EYE SYNDROMES; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; TEARS;

EID: 84879158076     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318285c912     Document Type: Article

References (27)

1. Dry Eye Workshop (DEWS) Committee. 2007 Report of the Dry Eye Workshop (DEWS) Ocul Surf. 2007;5:65-204.
2. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990; 33:160-172.
3. Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58:26-35.
4. Atzeni F, Cazzola M, Benucci M, et al. Chronic widespread pain in the spectrum of rheumatological diseases. Best Pract Res Clin Rheumatol. 2011;25:165-171.
5. Gallar J, Morales C, Freire V, et al. Decreased corneal sensitivity and tear production in fibromyalgia. Invest Ophthalmol Vis Sci. 2009;50:4129-4134.
6. Günaydin I, Terhorst T, Eckstein A, et al. Assessment of keratoconjunctivitis sicca in patients with fibromyalgia: results of a prospective study. Rheumatol Int. 1999;19:7-9.
7. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol. 1991;18:728-733.
8. Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int. 2000; 20:9-12.
9. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
10. Hisli N. Beck Depresyon envanterinin geçerliliǧi üzerine bir çali{dotless}şma. Türk Psikoloji Dergisi. 1989;22:118-126.
11. Irkec M; Turkish OSDI Study Group. Reliability and validity of Turkish translation of the Ocular Surface Disease Index (OSDI) in dry eye syndrome. Invest Ophthalmol Vis Sci. 2007;48:408-B610.
12. Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000; 118:615-621.
13. Lemp MA, Bron AJ, Baudouin C, et al. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol. 2011;151:792-798.e1.
14. Price EJ, Venables PJ. Dry eyes and mouth syndrome-a subgroup of patients with sicca symptoms. Rheumatology (Oxford). 2002;41:416-422.
15. Sullivan BD, Whitmer D, Nichols KK, et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci. 2010;51:6125-6130.
16. Schein OD, Tielsch JM, Munõz B, et al. Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. Ophthalmology. 1997;104:1395-1401.
17. Smith JA. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye Work Shop (2007). Ocul Surf. 2007;5:93-107.
18. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397-440.
19. Huang JF, Zhang Y, Rittenhouse KD, et al. Evaluations of tear protein markers in dry eye disease: repeatability of measurement and correlation with disease. Invest Ophthalmol Vis Sci. 2012;53:4556-4564.
20. Enríquez-de-Salamanca A, Castellanos E, Stern ME, et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis. 2010;16:862-873.
21. Uçeyler N, Häuser W, Sommer C. Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord. 2011; 12:245.
22. Kötter I, Neuscheler D, Günaydin I, et al. Is there a predisposition for the development of autoimmune diseases in patients with fibromyalgia? Retrospective analysis with long term follow-up. Rheumatol Int. 2007;27: 1031-1039.
23. Schaefer C, Chandran A, Hufstader M, et al. The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States. Health Qual Life Outcomes. 2011;9:71.
24. Homann D, Stefanello JM, Góes SM, et al. Stress perception and depressive symptoms: functionality and impact on the quality of life of women with fibromyalgia. Rev Bras Reumatol. 2012;52:319-330.
25. Wen W, Wu Y, Chen Y, et al. Dry eye disease in patients with depressive and anxiety disorders in Shanghai. Cornea. 2012;31:686-692.
26. Turkyilmaz A, Kurt EE, Karkucak M, et al. Sociodemographic characteristics, clinical signs and quality of life in patients with fibromyalgia. EAJM. 2012;44:88-93.
27. Le Q, Zhou X, Ge L, et al. Impact of dry eye syndrome on vision-related quality of life in a non-clinic-based general population. BMC Ophthalmol. 2012;12:22.